Search

everythinglearnresearchcommunity

for

Search:↓

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Hair loss in lupus patients indicates higher disease activity.

The document concludes that different types of permanent hair loss conditions are related and early treatment is key to preventing further damage.

Use antimalarials like hydroxychloroquine for cutaneous lupus, avoid herbal supplements, and focus on lifestyle changes like sun protection.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

RCM and OCT are effective for diagnosing and monitoring hair-related skin diseases but lack standardized protocols and need more research.

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

The study suggests that motor neurons created from stem cells of patients with spinal and bulbar muscular atrophy show signs of the disease, including changes in protein levels and cell functions.

Herbs might help with hair loss, but more research is needed to confirm their safety and effectiveness.

Cyclosporin A promotes hair cell growth and affects protein kinase C levels.

GC10/DOX hydrogel shows promise as an effective thyroid cancer treatment.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Basal cell carcinoma mostly starts from cells in the upper skin layers, not hair follicle stem cells.

Transplantation is effective for stable leucoderma but not for progressive, widespread vitiligo vulgaris.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

Targeting ornithine decarboxylase can help prevent skin cancer.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Basal cell carcinomas have much higher levels of Vitamin D3 receptors compared to healthy skin.

Adverse events from vismodegib can be managed effectively to ensure optimal treatment.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

Most people with basal cell carcinoma on their head or neck were 60-70 years old, and it often came back even after being fully removed, especially in certain areas and types.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Activating Notch signaling can kill basal cell carcinoma cells.